ICAM1 and COVID-19: In COVID-19, the association of sICAM-1 levels with patients’ severity was shown in ward patients, in whom serum levels of ICAM-1, amongst others, were dramatically elevated in severe cases, concluding that the increased expression of endothelial cell adhesion molecules is related to COVID-19 disease severity, and may contribute to coagulation dysfunction [29].